Results 71 to 80 of about 1,482 (173)

Effectiveness of Oral Tofacitinib Dose Tapering in a Case of Alopecia Areata Universalis. [PDF]

Skin Appendage Disord, 2021
Esteves M, Lopes S, Azevedo F, Pedrosa A.   +3 more
europepmc   +1 more source

Seasonal patterns in alopecia areata, totalis, and universalis [PDF]

Journal of the American Academy of Dermatology, 2018
Elana, Putterman, Leslie, Castelo-Soccio
openaire   +2 more sources

Jak inhibitors in the treatment of alopecia areata - a literature review

Journal of Education, Health and Sport
Introduction Alopecia areata (AA) is a chronic autoimmune disorder causing non-scarring hair loss, which can range from isolated patches to complete scalp (alopecia totalis, AT) or body hair loss (alopecia universalis, AU).
Paulina Krzeszowska, Aleksandra Kujawa, Karolina Krochmal, Wojciech Pisarek, Adrianna Samoraj, Jakub Zajączkowski, Kacper Stępniak, Jan Wilk, Karolina Marrodán-Wojtczak, Radosław Kuźma   +9 more
doaj   +1 more source

Evaluation of serum homocysteine, high-sensitivity CRP, and RBC folate in patients with alopecia areata

Indian Journal of Dermatology, 2014
Introduction: Alopecia areata (AA) is a common type of hair loss with an autoimmune basis. As the role of homocysteine (Hcys), folate, and CRP has been considered in some autoimmune diseases.
Maryam Yousefi, Mohammad Reza Namazi, Hoda Rahimi, Shima Younespour, Amir Houshang Ehsani, Safoura Shakoei   +5 more
doaj  

A Successful Treatment of Alopecia Universalis with Ruxolitinib

Journal of Dermatology and Dermatologic Surgery
Alopecia universalis (AU) is a type of alopecia areata, characterized by total body hair loss and often associated with profound psychosocial distress.
Lama M. Albelowi, Feras Beitar, Azad Kassim   +2 more
doaj   +1 more source

Clinical Experience with Oral Tofacitinib in a Patient with Alopecia Areata Universalis and Rheumatoid Arthritis. [PDF]

Int J Trichology, 2020
Abe DT, Tashima LM, Basilio FMA, Mulinari-Brenner F.   +3 more
europepmc   +1 more source

Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis [PDF]

Journal of the American Academy of Dermatology, 2018
Elana, Putterman, Leslie, Castelo-Soccio
openaire   +2 more sources

Alopecia Areata Universalis in the Onset of Autoimmune Polyendocrine Syndrome Type III C.

Int J Trichology, 2022
Neagu N, Morariu SH, Grama A.
europepmc   +1 more source

Alopecia areata: Treatment options [PDF]

Medicinski Glasnik, 2006
Alopecia areata (AA) is a common cause of reversible hair loss afflictingapproximately1-2%ofthegeneralpopulation. It commonly present as round patches of hair loss which can be the firstmanifestationofamoreseverealopecia totalis or universalis. The cause
E. Kasumagić-Halilović, A. Prohić
doaj  

Comparative investigation of immune-related biomarkers related to alopecia areata subtypes

Archives of Medical Science
Introduction The study aimed to explore the underlying immunologic mechanisms and immune-related biomarkers associated with alopecia areata (AA) development.
Huiwen Zheng, Yin Li, Chen Shen, Sha Zhou, Chunlan Huang, Xiaoxuan Guo, Yunling Li   +6 more
doaj   +1 more source